APPLICATION
ANDA065344
TYPE
ANDA
ORIGINAL APPROVAL
2009-01-15
LATEST ACTION
2024-05-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
AMOXICILLINDiscontinued
AMOXICILLIN 875MG · TABLET · ORAL
Approval history
2024-05-01Labeling · Supplement 8 · standardAP
2024-04-25Labeling · Supplement 6 · standardAP
2024-04-25Labeling · Supplement 7 · standardAP
2024-04-25Labeling · Supplement 5 · standardAP
2009-01-15OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.